Developing Quantitative Gtpase Affinity Purification (Qgap) to Identify Interaction Partners of Rho Gtpases

Total Page:16

File Type:pdf, Size:1020Kb

Developing Quantitative Gtpase Affinity Purification (Qgap) to Identify Interaction Partners of Rho Gtpases Developing quantitative GTPase affinity purification (qGAP) to identify interaction partners of Rho GTPases Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.) eingereicht im Fachbereich Biologie, Chemie, Pharmazie der Freien Universität Berlin vorgelegt von FLORIAN ERNST RUDOLF BENJAMIN PAUL (DIPL.-BIOCHEM.) Januar 2014 ii Die vorliegende Arbeit wurde von Oktober 2008 bis Januar 2014 am Max-Delbrück-Centrum für Molekulare Medizin unter der Anleitung von Prof. Dr. MATTHIAS SELBACH angefertigt. 1. Gutachter: Prof. Dr. MATTHIAS SELBACH Cell Signalling and Mass Spectrometry Max-Delbrück-Centrum, Berlin 2. Gutachter: Prof. Dr. UDO HEINEMANN Institut für Chemie / Biochemie Freie Universität Berlin / Max-Delbrück-Centrum, Berlin Disputation am 8. Mai 2014 iii iv “Study hard what interests you the most in the most undisciplined, irreverent and original manner possible.” ― Richard P. Feynman v vi Contents 1 Introduction ............................................................................................................................ 1 1.1 Rho GTPases ..................................................................................................................... 2 1.1.1 The GDP/GTP cycle .......................................................................................................... 2 1.1.2 Rho GTPases as part of the Ras superfamily ................................................................... 3 1.1.3 The family of Rho GTPases .............................................................................................. 4 1.2 Regulation of Rho GTPases ............................................................................................... 7 1.2.1 Guanine nucleotide exchange factors ............................................................................. 7 1.2.2 GTPase activating proteins .............................................................................................. 8 1.2.3 Guanine dissociation inhibitors ....................................................................................... 9 1.2.4 Subcellular localization .................................................................................................... 9 1.3 General concepts of Rho GTPase signaling ...................................................................... 10 1.3.1 Cell polarity .................................................................................................................... 10 1.3.2 Actin cytoskeleton ......................................................................................................... 10 1.3.3 Gene expression ............................................................................................................ 12 1.3.4 Enzymatic activity and cell cycle.................................................................................... 12 1.4 Disease relevance of Rho GTPases .................................................................................. 13 1.5 Mass spectrometry for Protein identification ................................................................. 14 1.5.1 Quantitative mass spectrometry ................................................................................... 15 1.5.2 Protein Identification and Quantification ..................................................................... 17 1.6 Protein Interactions and q-AP/MS .................................................................................. 17 1.6.1 Identification of Rho GTPase interaction partners ........................................................ 20 1.7 Objectives ...................................................................................................................... 21 2 Materials & Methods ............................................................................................................. 23 2.1 Materials ........................................................................................................................ 23 2.1.1 Chemicals ....................................................................................................................... 23 2.1.2 Media and buffers ......................................................................................................... 23 2.1.3 Enzymes/Proteins .......................................................................................................... 27 2.1.4 Antibodies ...................................................................................................................... 27 2.1.5 Kits ................................................................................................................................. 28 2.1.6 Bacteria strains .............................................................................................................. 28 2.1.7 Plasmids ......................................................................................................................... 28 2.1.8 Cell lines ......................................................................................................................... 28 2.1.9 cDNA clones ................................................................................................................... 29 2.2 Molecular biology methods ............................................................................................ 29 2.2.1 Primer design and Oligonucleotides ............................................................................. 29 2.2.2 Polymerase Chain Reaction ........................................................................................... 29 vii 2.2.3 DNA purification ............................................................................................................ 29 2.2.4 Restriction digest ........................................................................................................... 29 2.2.5 Agarose gel electrophoresis .......................................................................................... 29 2.2.6 DNA extraction .............................................................................................................. 29 2.2.7 Ligation .......................................................................................................................... 30 2.2.8 Transformation of chemically competent E. coli........................................................... 30 2.2.9 Long term storage of E. coli cultures ............................................................................ 30 2.2.10 Plasmid preparation ...................................................................................................... 30 2.3 Biochemical Methods ..................................................................................................... 30 2.3.1 Antibiotics ...................................................................................................................... 30 2.3.2 Protein expression in E. coli .......................................................................................... 31 2.3.3 E. coli cell lysis and preparation of the cytosolic fraction ............................................. 31 2.3.4 Glutathione affinity chromatography ........................................................................... 31 2.3.5 Size exclusion chromatography ..................................................................................... 31 2.3.6 Nucleotide loading ........................................................................................................ 32 2.3.7 Determination of protein-bound nucleotide ................................................................ 32 2.3.8 Protein concentration determination ........................................................................... 32 2.3.9 Protein concentration and storage ............................................................................... 32 2.3.10 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) .................... 32 2.3.11 Western blotting ........................................................................................................... 33 2.4 Cell cultivation, fractionation and lysis ........................................................................... 33 2.4.1 Cell media/SILAC............................................................................................................ 33 2.4.2 Cell cultivation ............................................................................................................... 33 2.4.3 Preparation of cytosolic extracts ................................................................................... 34 2.4.4 Transient transfection of mammalian cells ................................................................... 34 2.4.5 Lysis of adherent mammalian cells ............................................................................... 34 2.4.6 Preparation of mice brain .............................................................................................. 34 2.4.7 Immunoprecipitation (GFP-fusion proteins) ................................................................. 35 2.4.8 Pull down assay ............................................................................................................. 35 2.4.9 Protein ethanol precipitation ........................................................................................ 36 2.4.10 Proximity ligation assay ................................................................................................
Recommended publications
  • Snapshot: Formins Christian Baarlink, Dominique Brandt, and Robert Grosse University of Marburg, Marburg 35032, Germany
    SnapShot: Formins Christian Baarlink, Dominique Brandt, and Robert Grosse University of Marburg, Marburg 35032, Germany Formin Regulators Localization Cellular Function Disease Association DIAPH1/DIA1 RhoA, RhoC Cell cortex, Polarized cell migration, microtubule stabilization, Autosomal-dominant nonsyndromic deafness (DFNA1), myeloproliferative (mDia1) phagocytic cup, phagocytosis, axon elongation defects, defects in T lymphocyte traffi cking and proliferation, tumor cell mitotic spindle invasion, defects in natural killer lymphocyte function DIAPH2 Cdc42 Kinetochore Stable microtubule attachment to kinetochore for Premature ovarian failure (mDia3) chromosome alignment DIAPH3 Rif, Cdc42, Filopodia, Filopodia formation, removing the nucleus from Increased chromosomal deletion of gene locus in metastatic tumors (mDia2) Rac, RhoB, endosomes erythroblast, endosome motility, microtubule DIP* stabilization FMNL1 (FRLα) Cdc42 Cell cortex, Phagocytosis, T cell polarity Overexpression is linked to leukemia and non-Hodgkin lymphoma microtubule- organizing center FMNL2/FRL3/ RhoC ND Cell motility Upregulated in metastatic colorectal cancer, chromosomal deletion is FHOD2 associated with mental retardation FMNL3/FRL2 Constituently Stress fi bers ND ND active DAAM1 Dishevelled Cell cortex Planar cell polarity ND DAAM2 ND ND ND Overexpressed in schizophrenia patients Human (Mouse) FHOD1 ROCK Stress fi bers Cell motility FHOD3 ND Nestin, sarcomere Organizing sarcomeres in striated muscle cells Single-nucleotide polymorphisms associated with type 1 diabetes
    [Show full text]
  • Identification of a WNT5A-Responsive Degradation Domain in the Kinesin
    G C A T T A C G G C A T genes Article Identification of a WNT5A-Responsive Degradation Domain in the Kinesin Superfamily Protein KIF26B Edith P. Karuna ID , Shannon S. Choi, Michael K. Scales, Jennie Hum, Michael Cohen, Fernando A. Fierro and Hsin-Yi Henry Ho * ID Department of Cell Biology and Human Anatomy, School of Medicine, University of California, Davis, CA 95616, USA; [email protected] (E.P.K.); [email protected] (S.S.C.); [email protected] (M.K.S.); [email protected] (J.H.); [email protected] (M.C.); ffi[email protected] (F.A.F.) * Correspondence: [email protected]; Tel.: +1-530-752-8857 Received: 19 February 2018; Accepted: 26 March 2018; Published: 5 April 2018 Abstract: Noncanonical WNT pathways function independently of the β-catenin transcriptional co-activator to regulate diverse morphogenetic and pathogenic processes. Recent studies showed that noncanonical WNTs, such as WNT5A, can signal the degradation of several downstream effectors, thereby modulating these effectors’ cellular activities. The protein domain(s) that mediates the WNT5A-dependent degradation response, however, has not been identified. By coupling protein mutagenesis experiments with a flow cytometry-based degradation reporter assay, we have defined a protein domain in the kinesin superfamily protein KIF26B that is essential for WNT5A-dependent degradation. We found that a human disease-causing KIF26B mutation located at a conserved amino acid within this domain compromises the ability of WNT5A to induce KIF26B degradation. Using pharmacological perturbation, we further uncovered a role of glycogen synthase kinase 3 (GSK3) in WNT5A regulation of KIF26B degradation.
    [Show full text]
  • New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology
    Cancer Research and Treatment 2003;35(4):304-313 New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology Yong-Wan Kim, Ph.D.1, Min-Je Suh, M.S.1, Jin-Sik Bae, M.S.1, Su Mi Bae, M.S.1, Joo Hee Yoon, M.D.2, Soo Young Hur, M.D.2, Jae Hoon Kim, M.D.2, Duck Young Ro, M.D.2, Joon Mo Lee, M.D.2, Sung Eun Namkoong, M.D.2, Chong Kook Kim, Ph.D.3 and Woong Shick Ahn, M.D.2 1Catholic Research Institutes of Medical Science, 2Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul; 3College of Pharmacy, Seoul National University, Seoul, Korea Purpose: This study utilized both mRNA differential significant genes of unknown function affected by the display and the Gene Ontology (GO) analysis to char- HPV-16-derived pathway. The GO analysis suggested that acterize the multiple interactions of a number of genes the cervical cancer cells underwent repression of the with gene expression profiles involved in the HPV-16- cancer-specific cell adhesive properties. Also, genes induced cervical carcinogenesis. belonging to DNA metabolism, such as DNA repair and Materials and Methods: mRNA differential displays, replication, were strongly down-regulated, whereas sig- with HPV-16 positive cervical cancer cell line (SiHa), and nificant increases were shown in the protein degradation normal human keratinocyte cell line (HaCaT) as a con- and synthesis. trol, were used. Each human gene has several biological Conclusion: The GO analysis can overcome the com- functions in the Gene Ontology; therefore, several func- plexity of the gene expression profile of the HPV-16- tions of each gene were chosen to establish a powerful associated pathway, identify several cancer-specific cel- cervical carcinogenesis pathway.
    [Show full text]
  • A Global Transcriptional Network Connecting Noncoding Mutations to Changes in Tumor Gene Expression
    HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Genet Manuscript Author . Author manuscript; Manuscript Author available in PMC 2018 October 02. Published in final edited form as: Nat Genet. 2018 April ; 50(4): 613–620. doi:10.1038/s41588-018-0091-2. A global transcriptional network connecting noncoding mutations to changes in tumor gene expression Wei Zhang1,†,*, Ana Bojorquez-Gomez1,†, Daniel Ortiz Velez2, Guorong Xu3, Kyle S. Sanchez1, John Paul Shen1, Kevin Chen2, Katherine Licon1, Collin Melton4, Katrina M. Olson1,5, Michael Ku Yu1, Justin K. Huang1,6, Hannah Carter1, Emma K. Farley1,5, Michael Snyder4, Stephanie I. Fraley2, Jason F. Kreisberg1,*, and Trey Ideker1,2,6,* 1Department of Medicine, University of California, San Diego, La Jolla, California, USA 2Department of Bioengineering, University of California San Diego, La Jolla, CA, USA 3Center for Computational Biology and Bioinformatics, University of California, San Diego, La Jolla, California, USA 4Department of Genetics, Stanford University School of Medicine, Stanford, California, USA 5Division of Biological Sciences, University of California San Diego, La Jolla, CA, USA 6Bioinformatics and Systems Biology Program, UC San Diego, La Jolla, California, USA Abstract Although cancer genomes are replete with noncoding mutations, the effects of these mutations remain poorly characterized. Here we perform an integrative analysis of 930 tumor whole genomes and matched transcriptomes, identifying a network of 193 noncoding loci in which mutations disrupt target gene expression. These “somatic eQTLs” (expression Quantitative Trait Loci) are frequently mutated in specific cancer tissues, and the majority can be validated in an independent cohort of 3,382 tumors. Among these, we find that the effects of noncoding mutations on DAAM1, MTG2 and HYI transcription are recapitulated in multiple cancer cell lines, and that increasing DAAM1 expression leads to invasive cell migration.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Actin-Bound Structures of Wiskott–Aldrich Syndrome Protein (WASP)-Homology Domain 2 and the Implications for Filament Assembly
    Actin-bound structures of Wiskott–Aldrich syndrome protein (WASP)-homology domain 2 and the implications for filament assembly David Chereau, Frederic Kerff, Philip Graceffa, Zenon Grabarek, Knut Langsetmo, and Roberto Dominguez* Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472 Edited by Thomas D. Pollard, Yale University, New Haven, CT, and approved September 28, 2005 (received for review August 12, 2005) Wiskott–Aldrich syndrome protein (WASP)-homology domain 2 It has been proposed, based on sequence analysis, that WH2 (WH2) is a small and widespread actin-binding motif. In the WASP forms part of an extended family with the thymosin ␤ domain family, WH2 plays a role in filament nucleation by Arp2͞3 complex. (T␤) (7). However, this view is controversial, in part because of Here we describe the crystal structures of complexes of actin with the different biological functions and low sequence similarity of the WH2 domains of WASP, WASP-family verprolin homologous WH2 and T␤ (8). The actin-bound structures of the N-terminal protein, and WASP-interacting protein. Despite low sequence iden- half of ciboulot domain 1 (9) and that of a hybrid protein tity, WH2 shares structural similarity with the N-terminal portion of consisting of gelsolin domain 1 and the C-terminal half of T␤4 the actin monomer-sequestering thymosin ␤ domain (T␤). We (10) have been reported. These structures have been combined show that both domains inhibit nucleotide exchange by targeting into a model of T␤4–actin (10), and, although both T␤4 and the cleft between actin subdomains 1 and 3, a common binding site ciboulot belong in the T␤ family, their structures have been for many unrelated actin-binding proteins.
    [Show full text]
  • Bundling of Cytoskeletal Actin by the Formin FMNL1 Contributes to Celladhesion and Migration
    Bundling of cytoskeletal actin by the formin FMNL1 contributes to celladhesion and migration Item Type Dissertation Authors Miller, Eric Rights Attribution-NonCommercial-NoDerivatives 4.0 International Download date 27/09/2021 05:11:17 Item License http://creativecommons.org/licenses/by-nc-nd/4.0/ Link to Item http://hdl.handle.net/20.500.12648/1760 Bundling of cytoskeletal actin by the formin FMNL1 contributes to cell adhesion and migration Eric W. Miller A Dissertation in the Department of Cell and Developmental Biology Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the College of Graduate Studies of State University of New York, Upstate Medical University Approved ______________________ Dr. Scott D. Blystone Date______________________ i Table of Contents Title Page-------------------------------------------------------------------------------------------------------i Table of Contents-------------------------------------------------------------------------------------------ii List of Tables and Figures------------------------------------------------------------------------------vi Abbreviations----------------------------------------------------------------------------------------------viii Acknowledgements--------------------------------------------------------------------------------------xiii Thesis Abstract-------------------------------------------------------------------------------------------xvi Chapter 1: General Introduction-----------------------------------------------------------------------1
    [Show full text]
  • Anillin Is a Prognostic Factor and Is Correlated with Genovariation in Pancreatic Cancer Based on Databases Analysis
    ONCOLOGY LETTERS 21: 107, 2021 Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis YUANHUA NIE, ZHIQIANG ZHAO, MINXUE CHEN, FULIN MA, YONG FAN, YINGXIN KANG, BOXIONG KANG and CHEN WANG Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, P.R. China Received March 12, 2020; Accepted October 8, 2020 DOI: 10.3892/ol.2020.12368 Abstract. Pancreatic cancer has a low survival rate globally. PC pathways were associated with low expression of ANLN. Anillin (ANLN) is involved in the pathogenesis of pancreatic Overall, ANLN is more highly expressed in PC compared cancer (PC). The present study used databases and reverse with in normal tissue, and is associated with poor differen‑ transcription‑quantitative PCR to investigate the association tiation. The expression of ANLN may be a novel prognostic between ANLN expression, clinical variables and the survival marker of poor survival. Finally, ANLN exert its functions in rate of patients with pancreatic cancer. Gene expression PC through the p53, cell cycle, DNA replication, mismatch of ANLN in normal and cancer tissues was analyzed using repair and nucleotide excision repair and pathways. data from The Cancer Genome Atlas, Oncomine and Gene Expression database of Normal and Tumor tissues 2 and Introduction ANOVA, and the association between ANLN mRNA expres‑ sion and ANLN genovariation was analyzed using cBioPortal. Pancreatic cancer (PC) is a major public health problem The association between ANLN expression and the survival, and is the eleventh most common cancer in the world, with clinical, pathological and prognostic characteristics of PC 458,918 new cases and 432,242 deaths in 2018 (1).
    [Show full text]
  • S41467-020-18249-3.Pdf
    ARTICLE https://doi.org/10.1038/s41467-020-18249-3 OPEN Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain Lei Zhao1,2,17, Zhongqi Li 1,2,17, Joaquim S. L. Vong2,3,17, Xinyi Chen1,2, Hei-Ming Lai1,2,4,5,6, Leo Y. C. Yan1,2, Junzhe Huang1,2, Samuel K. H. Sy1,2,7, Xiaoyu Tian 8, Yu Huang 8, Ho Yin Edwin Chan5,9, Hon-Cheong So6,8, ✉ ✉ Wai-Lung Ng 10, Yamei Tang11, Wei-Jye Lin12,13, Vincent C. T. Mok1,5,6,14,15 &HoKo 1,2,4,5,6,8,14,16 1234567890():,; The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovas- cular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation- dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which pro- minently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed tran- scriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.
    [Show full text]
  • G Protein Regulation of MAPK Networks
    Oncogene (2007) 26, 3122–3142 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW G Protein regulation of MAPK networks ZG Goldsmith and DN Dhanasekaran Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA G proteins provide signal-coupling mechanisms to hepta- the a-subunits has been used as a basis for the helical cell surface receptors and are criticallyinvolved classification of G proteins into Gs,Gi,Gq and G12 in the regulation of different mitogen-activated protein families in which the a-subunits that show more than kinase (MAPK) networks. The four classes of G proteins, 50% homology are grouped together (Simon et al., defined bythe G s,Gi,Gq and G12 families, regulate 1991). In G-protein-coupled receptor (GPCR)-mediated ERK1/2, JNK, p38MAPK, ERK5 and ERK6 modules by signaling pathways, ligand-activated receptors catalyse different mechanisms. The a- as well as bc-subunits are the exchange of the bound GDP to GTP in the a-subunit involved in the regulation of these MAPK modules in a following which the GTP-bound a-subunit disassociate context-specific manner. While the a- and bc-subunits from the receptor as well as the bg-subunit. The GTP- primarilyregulate the MAPK pathwaysvia their respec- bound a-subunit and the bg-subunit stimulate distinct tive effector-mediated signaling pathways, recent studies downstream effectors including enzymes, ion channels have unraveled several novel signaling intermediates and small GTPase, thus regulating multiple signaling including receptor tyrosine kinases and small GTPases pathways including those involved in the activation of through which these G-protein subunits positivelyas well mitogen-activated protein kinase (MAPK) modules as negativelyregulate specific MAPK modules.
    [Show full text]
  • Myopia in African Americans Is Significantly Linked to Chromosome 7P15.2-14.2
    Genetics Myopia in African Americans Is Significantly Linked to Chromosome 7p15.2-14.2 Claire L. Simpson,1,2,* Anthony M. Musolf,2,* Roberto Y. Cordero,1 Jennifer B. Cordero,1 Laura Portas,2 Federico Murgia,2 Deyana D. Lewis,2 Candace D. Middlebrooks,2 Elise B. Ciner,3 Joan E. Bailey-Wilson,1,† and Dwight Stambolian4,† 1Department of Genetics, Genomics and Informatics and Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, United States 2Computational and Statistical Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, United States 3The Pennsylvania College of Optometry at Salus University, Elkins Park, Pennsylvania, United States 4Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, United States Correspondence: Joan E. PURPOSE. The purpose of this study was to perform genetic linkage analysis and associ- Bailey-Wilson, NIH/NHGRI, 333 ation analysis on exome genotyping from highly aggregated African American families Cassell Drive, Suite 1200, Baltimore, with nonpathogenic myopia. African Americans are a particularly understudied popula- MD 21131, USA; tion with respect to myopia. [email protected]. METHODS. One hundred six African American families from the Philadelphia area with a CLS and AMM contributed equally to family history of myopia were genotyped using an Illumina ExomePlus array and merged this work and should be considered co-first authors. with previous microsatellite data. Myopia was initially measured in mean spherical equiv- JEB-W and DS contributed equally alent (MSE) and converted to a binary phenotype where individuals were identified as to this work and should be affected, unaffected, or unknown.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]